CytoDyn Announces Investor Call To Provide Update On Clinical Development Strategy

CytoDyn Inc. , a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, announced today that the Company will host a live conference call and webcast with the investment community on Tuesday, March 25, 2014 at 1:30 p.m. PT to provide an update on the Company's clinical development ... (more)

http://ift.tt/1l3TaWK